학술논문

SOX2 dosage sustains tumor-promoting inflammation to drive disease aggressiveness by modulating the FOSL2/IL6 axis
Document Type
Article
Source
In: Molecular Cancer. (Molecular Cancer, December 2023, 22(1))
Subject
Language
English
ISSN
14764598